TerrAscend (TER) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
4 Sep, 2026Industry overview and market outlook
U.S. cannabis retail sales are projected to reach $56.9 billion by 2028, with 70% of Americans supporting legalization and 42 states having legalized cannabis in some form as of 2024.
Over 50% of the U.S. population lives in states with legal cannabis, with the user base expected to grow to 122 million by 2028.
Regulatory catalysts include the rescheduling of medical cannabis to Schedule III and the reintroduction of the SAFER Banking Act.
Company strategy and operations
Focus on revenue and market share growth through depth in attractive states, operational excellence, and expansion into new markets.
Vertically integrated operations across five U.S. states, with 20 dispensaries and four cultivation/production facilities.
Holds the #3 market share position in the Northeast and generates the highest revenue per store among competitors.
Leading brands include Kind Tree, Legend, Valhalla, and State Flower, with a strong retail presence and customer experience focus.
Financial performance and highlights
Q2 2026 net revenue from continuing operations was $67.1 million, up from $65.5 million in Q1 2026.
Gross profit margin improved to 54.0%, a 120 basis point increase quarter-over-quarter.
Adjusted EBITDA from continuing operations reached $17.7 million (26.3% margin), with positive net cash from operations for the 16th consecutive quarter.
Free cash flow was $5.7 million, marking the 12th consecutive quarter of positive free cash flow.
Cash and cash equivalents stood at $42.0 million as of June 30, 2026.
Latest events from TerrAscend
- Shareholders approved a share consolidation resolution at a virtual meeting with no questions submitted.TER
AGM 2026 - Q2 2026 delivered revenue and margin growth, robust cash flow, and key steps for future expansion.TER
Q2 2026 - All agenda items, including director elections and compensation plans, were approved by shareholders.TER
AGM 2026 - Q1 2026 saw $65.5M revenue, margin gains, and robust cash flow amid strategic U.S. expansion.TER
Investor presentation - Q1 2026 saw $65.5M revenue, strong margins, and regulatory changes boosting future prospects.TER
Q1 2026 - Top-three Northeast market share, $260.6M FY25 revenue, and 14 straight quarters of positive cash flow.TER
Investor presentation - Q4 and FY 2025 saw strong margins, positive cash flow, and disciplined expansion.TER
Q4 2025 - All business items, including director elections and stock option extension, were approved.TER
AGM 2024 - Revenue and EBITDA grew in Q2, with strong cash flow and $140M financing for expansion.TER
Q2 2024